An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica What is the recommended use and safety profile of Peptide BPC (Body Protection Compound) 157? BPC 157 Wikipedia The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York US FDA is expected to lift restriction on certain peptides, NYT reports Reuters